Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Omene CO, Wu J, Frenkel K
The manufacturers of GLP1-RAs typically recommend lowering doses of insulin and insulin secretagogues at the initiation of GLP-1 RA treatment to reduce the risk of hypoglycemia
GLP-1 consumers purchase foodservice offerings from convenience 13% more on a monthly basis than non-users
He is uniquely qualified to explain how GLP-1 RAs are changing the landscape for patients with and without diabetes and their providers
Powers JE et al
miR-139-5p promotes neovascularization in diabetic retinopathy by regulating the phosphatase and tensin homolog
US$ 21.01
US$ 23.90
US$ 29.15
US$ 24.86
US$ 23.02
US$ 20.70
US$ 25.10
